KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Retained Earnings (2017 - 2026)

Guardant Health's Retained Earnings history spans 9 years, with the latest figure at -$3.0 billion for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 57475.7% to -$3.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.0 billion, a 57475.7% decrease, with the full-year FY2025 number at -$3.0 billion, down 57475.7% from a year prior.
  • Retained Earnings hit -$3.0 billion in Q4 2025 for Guardant Health, down from -$4.3 million in the prior quarter.
  • Over the last five years, Retained Earnings for GH hit a ceiling of $904000.0 in Q1 2021 and a floor of -$3.0 billion in Q4 2025.
  • Historically, Retained Earnings has averaged -$619.7 million across 5 years, with a median of -$10.3 million in 2023.
  • Biggest five-year swings in Retained Earnings: skyrocketed 100.01% in 2021 and later crashed 125216.48% in 2022.
  • Tracing GH's Retained Earnings over 5 years: stood at -$1.0 billion in 2021, then soared by 98.06% to -$19.5 million in 2022, then skyrocketed by 81.18% to -$3.7 million in 2023, then crashed by 41.52% to -$5.2 million in 2024, then tumbled by 57475.7% to -$3.0 billion in 2025.
  • Business Quant data shows Retained Earnings for GH at -$3.0 billion in Q4 2025, -$4.3 million in Q3 2025, and -$3.7 million in Q2 2025.